{
  "type": "article",
  "title": "Mahajan Imaging & Labs and Neuburg Diagnostics Form Strategic Partnership to Boost Pathology and Wellness Business",
  "summary": "Mahajan Imaging & Labs has entered into a strategic joint venture partnership with Neuburg Diagnostics to expand its pathology and wellness services across North India. Kabir Mahajan has been appointed as the Chief Executive Officer of the joint venture.",
  "content": "In a major development aimed at strengthening healthcare and medical testing, Mahajan Imaging & Labs has announced a strategic joint venture partnership with Neuburg Diagnostics. The primary objective of this alliance is to rapidly expand pathology and wellness services across new and untapped geographical regions in North India. Through this collaboration, both companies will work toward integrating radiology, pathology, nuclear medicine, and genomics services under one roof.\n\nMahajan Imaging & Labs brings over 35 years of extensive experience in advanced imaging, nuclear medicine, pathology, and genomics, with a strong and established presence in the Delhi-NCR and Jaipur markets. In contrast, Neuburg Diagnostics operates not only across India but also in international markets including the UAE, South Africa, and the United States, and is widely recognized for its specialized capabilities in pathology and genomics.\n\nComprehensive Expansion of Testing Capabilities\nAccording to joint statements released by the companies, this alliance will significantly widen testing capabilities in cutting-edge fields such as genomics, metabolomics, proteomics, and molecular pathology. The core objective is to create a more integrated diagnostics platform, enabling patients to access comprehensive testing under one roof with superior quality standards. Heavy investments in lab infrastructure, sample collection networks, and advanced testing will cater to the rising demand for healthcare services.\n\nUnder the terms of the agreement, Mahajan Imaging & Labs will serve as the exclusive partner for Neuburg Diagnostics across 7 states in North India. As part of this arrangement, Mahajan Imaging & Labs will take over the existing laboratory operations of Neuburg in Noida, Lucknow, and Jammu. The overall day-to-day operations, management, and growth of the joint venture have been entrusted to Kabir Mahajan, who has been appointed as the Chief Executive Officer (CEO).\n\nMarket Growth and Industry Outlook\nThis strategic partnership comes at a time when India's organized diagnostics sector is evolving beyond conventional testing toward preventive, specialized, and precision diagnostics. According to industry estimates by ICRA, the revenues of organized diagnostics companies are projected to witness a robust growth of 12 to 14 percent in the financial year 2027. Companies believe this is an opportune move to capitalize on the surging demand through targeted investments.\n\nLeadership Perspectives\nDr. GSK Velu, Founder, Chairman, and Managing Director of Neuburg Diagnostics, noted that the 35-plus years of legacy and strong clinical footprint of Mahajan Imaging & Labs in North India make it a natural and precise partner for Neuburg. He expressed confidence that Neuburg's strengths in pathology, genomics, wellness, and digital infrastructure will further reinforce this solid foundation.\n\nOn the other hand, Dr. Harsh Mahajan, Founder and Chairman of Mahajan Imaging & Labs, emphasized modern medical science by stating that radiology, pathology, and genomics can no longer be viewed in isolation. Integrating insights from imaging, pathology, molecular testing, and genomics together has become vital for accurate clinical decision-making. He added that the partnership with Neuburg will help scale existing capabilities rapidly through additional infrastructure and expertise.\n\nFocus on Artificial Intelligence and Digital Systems\nKabir Mahajan, CEO of the joint venture, outlined that the immediate priority is the effective execution of the partnership. The company will strengthen collection, sample logistics, and digital systems alongside pathology, genomics, and wellness services. Special attention will also be paid to improving the turnaround time for test reports. The integration of technology and Artificial Intelligence (AI) will be expanded significantly across quality control, workflow management, and reporting.\n\nNotably, Mahajan Imaging & Labs currently operates 16 advanced diagnostic centers and laboratories in the Delhi-NCR region alone, alongside its established presence in Jaipur. The company provides a wide array of high-end medical services, including advanced imaging, MRI, CT scans, PET-CT scans, nuclear medicine, ultrasound, mammography, pathology, molecular diagnostics, and genomics.\n\nWhat this means for you\nThis strategic partnership in the healthcare and diagnostic testing sector carries significant implications for patients and the broader medical industry.\n\n• Across India: The expansion of the organized diagnostics sector, backed by projected revenue growth of 12 to 14 percent in FY 2027, will improve nationwide access to preventive and advanced testing services.\n• In Northern States and Local Hubs: With Mahajan taking over Neuburg's lab operations in key cities like Noida, Lucknow, and Jammu, local patients will gain direct access to advanced medical facilities such as genomics, molecular pathology, and specialized imaging closer to home.\n\nQuestions & Answers\n\n1. Which company has Mahajan Imaging & Labs partnered with?\nMahajan Imaging & Labs has entered into a strategic joint venture partnership with Neuburg Diagnostics.\n\n2. Who has been appointed as the Chief Executive Officer (CEO) of the joint venture?\nKabir Mahajan has been appointed as the Chief Executive Officer of the joint venture.\n\n3. How many states in North India will be covered under this partnership?\nThe partnership will cover 7 states in North India, with Mahajan acting as Neuburg's exclusive partner.\n\n4. Which existing labs will be taken over by Mahajan?\nMahajan Imaging & Labs will take over Neuburg's existing laboratory operations in Noida, Lucknow, and Jammu.\n\n5. What revenue growth does ICRA project for the organized diagnostics sector in FY 2027?\nAccording to ICRA estimates, revenues of organized diagnostics companies could grow by 12 to 14 percent in the financial year 2027.",
  "url": "https://trendkia.com/en/business/mahajan-imaging-labs-aur-neuburg-diagnostics-ne-milaya-hath-uttar-bharat-me-pathology-aur-wellness-karobar-ko-milegi-raftar-25255",
  "category": "Business",
  "publishedAt": "2026-08-31",
  "tags": [
    "Mahajan Imaging Labs",
    "Neuburg Diagnostics",
    "Joint Venture",
    "Pathology",
    "Genomics",
    "Kabir Mahajan",
    "Dr Harsh Mahajan",
    "Dr GSK Velu"
  ],
  "language": "en",
  "site": "TrendKia"
}